Borderline Resectable, Locally Advanced or Metastatic Pancreatic Cancer
1 clinical trials · Condition
◉ Watch Borderline Resectable, Locally Advanced or Metastatic Pancreatic Cancer
| Record | Firm | Date |
|---|---|---|
| Nivolumab, Ipilimumab and Chemoradiation in Pancreatic Cancer. (NCT04247165) | Herlev Hospital | 2020-06-02 |
Track Borderline Resectable, Locally Advanced or Metastatic Pancreatic Cancer automatically
Every clearance here is in the API, with alerts when new ones post.